Cellectar Biosciences (CLRB) Investor Presentation - Slideshow

| --- | --- | --- | |---------------------------|-------|-------| | | | | | | | | | | | | | | | | | CELLECTAR BIOSCIENCES (3) | | | | | | | | lopofosine l 131 | | | | | | | | | | | Iopofosine I 131: Lead Candidate First-in-class Phospholipid Ether Radiotherapeutic to Target Cancer 5 Iopofosine I 131: WM Phase 2a Response Rates Forward Looking Statements and Disclaimers This presentation contains forward-looking statements. Such statements are valid only as of today and we disclaim any obligation to update t ...